Abstract
OnabotulinumtoxinA was introduced to the US market in 2002 as the first botulinum toxin type A (BoNTA) approved for facial aesthetics. This article provides an overview of onabotulinumtoxinA's uses and indications as well as safety and efficacy data. As with other BoNTA products, onabotulinumtoxinA is generally well tolerated. Consideration is also given to clinical applications of the product. Information on handling, storage, and dosing is provided.
| Original language | English (US) |
|---|---|
| Journal | Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery |
| Volume | 33 |
| Issue number | 1 Suppl |
| DOIs | |
| State | Published - Mar 2013 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
A review of onabotulinumtoxinA (Botox). / Lorenc, Z. Paul; Kenkel, Jeffrey M.; Fagien, Steven; Hirmand, Haideh; Nestor, Mark S.; Sclafani, Anthony P.; Sykes, Jonathan M; Waldorf, Heidi A.
In: Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery, Vol. 33, No. 1 Suppl, 03.2013.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A review of onabotulinumtoxinA (Botox).
AU - Lorenc, Z. Paul
AU - Kenkel, Jeffrey M.
AU - Fagien, Steven
AU - Hirmand, Haideh
AU - Nestor, Mark S.
AU - Sclafani, Anthony P.
AU - Sykes, Jonathan M
AU - Waldorf, Heidi A.
PY - 2013/3
Y1 - 2013/3
N2 - OnabotulinumtoxinA was introduced to the US market in 2002 as the first botulinum toxin type A (BoNTA) approved for facial aesthetics. This article provides an overview of onabotulinumtoxinA's uses and indications as well as safety and efficacy data. As with other BoNTA products, onabotulinumtoxinA is generally well tolerated. Consideration is also given to clinical applications of the product. Information on handling, storage, and dosing is provided.
AB - OnabotulinumtoxinA was introduced to the US market in 2002 as the first botulinum toxin type A (BoNTA) approved for facial aesthetics. This article provides an overview of onabotulinumtoxinA's uses and indications as well as safety and efficacy data. As with other BoNTA products, onabotulinumtoxinA is generally well tolerated. Consideration is also given to clinical applications of the product. Information on handling, storage, and dosing is provided.
UR - http://www.scopus.com/inward/record.url?scp=84882937423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882937423&partnerID=8YFLogxK
U2 - 10.1177/1090820X12474629
DO - 10.1177/1090820X12474629
M3 - Article
C2 - 23515199
AN - SCOPUS:84882937423
VL - 33
JO - Aesthetic Surgery Journal
JF - Aesthetic Surgery Journal
SN - 1090-820X
IS - 1 Suppl
ER -